In our previous study, we found that ANO1 promotes ESCC cell proliferation, migration, and invasion by activating the TGF‐β pathway, suggesting that ANO1 is a novel oncogene and may serve as a potential therapeutic target in ESCC.17 Here, ANO1 is linked to esophageal squamous cell carcinoma.